In 2020, one of our co-founders witnessed firsthand the life-changing impact of losing independence when a close family member was diagnosed with a neurological condition. Watching a loved one struggle with even the simplest daily tasks sparked a powerful question: What if we could give that independence back?
That question became the driving force behind Bioliberty. Inspired by a shared vision, Rowan, Ross, Shéa, and Conan combined their engineering expertise and passion for innovation to create intuitive, accessible therapy tools to help individuals regain mobility, independence, and quality of life.
We’re shaping a future where recovery from mobility-limiting conditions and injuries is more personalized, accessible, and effective – so patients can regain their independence.
Bioliberty is founded
First fundamental patent granted
$3m pre-seed raise completed to support product development
Clinical study kick-starts with Mount Sinai health system. Lifehub and Lifeglov are FDA registered
Team expanded 3x, including key hires in the United States
With our UK headquarters located at The National Robotarium—the home of UK robotics and AI—we have direct access to world-class facilities and a thriving network of researchers and industry pioneers. Being part of this unique environment empowers us to push the boundaries of robotic technology and AI, transforming what’s possible in patient therapy.
Our US headquarters are in Boston—a city synonymous with innovation, world-class hospitals, and cutting-edge research. Boston provides the ideal base for collaborating with clinicians, accelerating clinical validation, and bringing our technology to the US market.
Our team brings together expertise from leading academic institutions and industry, with specialized skills in engineering, occupational therapy and design. United by a shared mission, we are dedicated to improving the lives of patients — supporting recovery from mobility-restricting conditions.